Literature DB >> 24018477

Neurodegenerative disease: PDK1--a common therapeutic target for AD and prion disease?

Heather Wood.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24018477     DOI： 10.1038/nrneurol.2013.193

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN： 1759-4758            Impact factor:   42.937


× No keyword cloud information.
  1 in total

1.  PDK1 decreases TACE-mediated α-secretase activity and promotes disease progression in prion and Alzheimer's diseases.

Authors:  Mathéa Pietri; Caroline Dakowski; Samia Hannaoui; Aurélie Alleaume-Butaux; Julia Hernandez-Rapp; Audrey Ragagnin; Sophie Mouillet-Richard; Stéphane Haik; Yannick Bailly; Jean-Michel Peyrin; Jean-Marie Launay; Odile Kellermann; Benoit Schneider
Journal:  Nat Med       Date:  2013-08-18       Impact factor: 53.440
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.